Viral Vector and Plasmid DNA Testing Services Market Analysis-2027

VIRAL VECTOR AND PLASMID DNA TESTING SERVICES MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027

© Coherent market Insights. All Rights Reserved

REPORT DESCRIPTION Viral Vector and Plasmid DNA Testing Services Market - Overview Global Viral Vector and Plasmid DNA Testing Services Market, by Testing Services (Safety, Genetic Characterization, Purity, Identity, and Potency), by End User (Research Organizations and Pharmaceutical and Biotechnological Companies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 76.4 million in 2018 and is expected to exhibit a CAGR of 25.0% over the forecast period (2019-2027), as highlighted in a new report published by Coherent Market Insights.

The increasing focus of market players on developing innovative techniques in order enhance the characterization of viral vectors are expected to drive growth of the viral vector and plasmid DNA testing services market over the forecast period. For instance, Promega Corporation developed Vac-Man 96 Vacuum Manifold, which supports processing of SV 96 plates for plasmid, genomic, and PCR product purification. Moreover, in September 2019, BIA Separations launched CORNERSTONE AAV Process Development Service. With this launch the company introduced CIMasphere, a purification technology that enables removal of host cell protein and host cell DNA before manufacturing, in order to deliver pure AAV products.

Major players are focused on collaborations and acquisitions, which is expected to propel the market growth over the forecast period. For instance, in November 2019, Lonza entered into a gene therapy collaboration with DiNAQOR AG. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/viralvector-and-plasmid-dna-testing-services-market-3637 Š Coherent market Insights. All Rights Reserved

REPORT DESCRIPTION Browse 26 Market Data Tables and 22 Figures spread through 145 pages and in-depth TOC on ‘Viral Vector and Plasmid DNA Testing Services Market’- global forecast to 2027, by Testing Services (Safety, Genetic Characterization, Purity, Identity, and Potency), by End User (Research Organizations, Pharmaceutical, and Biotechnological Companies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)' North America is expected to hold a dominant position in the viral vector and plasmid DNA testing services market, owing to adoption of inorganic growth strategies such as mergers, partnerships, and acquisitions by market players, in order to expand their product portfolio and strengthen their market presence, which in turn are expected to fuel growth of the regional market over the forecast period. For instance, in February 2019, Charles River Laboratories, Inc. acquired Citoxlab, a non-clinical CRO that offers regulated safety assessment services, non-regulated discovery services, and medical device testing services for around US$ 510 million. The acquisition resulted in expansion of Charles River’s global presence as a leading contract research organization (CRO) and enhanced its offerings in the market.

Furthermore, in September 2016, Charles River Laboratories, Inc. and PathoQuest entered into a partnership, in order to offer improved viral safety service to biopharmaceutical companies.

Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/3637 © Coherent market Insights. All Rights Reserved

REPORT DESCRIPTION Key Takeaways of the Viral Vector and Plasmid DNA Testing Services Market: The global viral vector and plasmid DNA testing services market is expected to exhibit a CAGR of 25.0% over the forecast period, owing to rising business expansion by inaugurating facility centers, merger and acquisitions, product launches, and others by market players. For instance, in May 2016, Merck KGaA announced capacity expansion of operations at its Carlsbad, California facility, in order to offer cell and gene therapy services. The facility also supports development of products from clinical to commercial scales.

Among testing services, safety segment held a dominant position in the viral vector and plasmid DNA testing services market in 2018, owing to increasing product or service launches by the manufacturers, which is expected to propel the market growth. For instance, in September 2018, Merck KGaA launched GMP BioReliance biosafety testing laboratory in Singapore to expand its clinical testing services in the Asia Pacific market. Moreover, in January 2020, LabCorp launched a suite of cell and gene therapy development solutions from its drug development business of Covance. The solution is developed to accelerate the development of cell and gene therapy.

Companies operating in the global viral vector and plasmid DNA testing services market include Charles River Laboratories, Inc., WuXi AppTec Co., Ltd., Cobra Biologics and Pharmaceutical Services, Merck KGaA, Lonza, Eurofins Scientific, FinVector Vision Therapies, Advanced Bioscience Laboratories, Inc., Takara Bio Inc., ViruSure GmbH, and Genezen Laboratories

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3637 Š Coherent market Insights. All Rights Reserved

ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.

SERVICES INDUSTRY ANALYSIS

CUSTOMIZED RESEARCH

SYNDICATED RESEARCH

MARKET INTELLIGENCE SERVICES

CONSULT STUDIES

COUNTRY SPECIFIC STUDIES

Š Coherent market Insights. All Rights Reserved

ABOUT CMI SECTOR COVERAGE

BIOTECHNOLOGY

CLINICAL DIAGNOSTIC

HEALTHCARE IT

MEDICAL DEVICES

MEDICAL IMAGING

PHARMACEUTICAL

OUR CLIENTS

 Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry

 Component Providers and System Integrators

 Private and Government organization

 Distributors, Retailors and Value Added Resellers

 Outsourcing Companies

 Healthcare IT Solutions Developers

 Universities and Business Schools.

© Coherent market Insights. All Rights Reserved

KEY STATS

RESEARCH SOLUTIONS

100+

FEASIBILITY STUDIES

Insights Published Per Year

GLOBAL REPORTS

150+

Consulting Projects Till Date

COUNTRY ANALYSIS CONSULT PROJECTS

125+

Clients Worldwide Per Year

110+

SURVEY RESEARCH

EXCEL FORECAST DATABASE

CUSTOMIZED SOLUTIONS

COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS

Analysts and Contract Consultants

Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702

Š Coherent market Insights. All Rights Reserved